mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |